United Kingdom· GB-APID-37399011000001107
Eklira 322micrograms/dose Genuair
A medicinal product containing aclidinium bromide, registered in United Kingdom by Mawdsley-Brooks & Company Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Aclidinium bromide
- Manufacturer
- Mawdsley-Brooks & Company Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aclidinium bromide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRETARIS GENUAIRCovis Pharma Europe B.V., Amsterdam
- BelgiumBretaris Genuair 322 µgCovis Pharma Europe
- FinlandBretaris GenuairCOVIS PHARMA EUROPE B.V.
- IrelandBretaris Genuair 322 micrograms inhalation powderCovis Pharma Europe B.V.
- SwitzerlandEklira Genuair
- SpainBRETARIS GENUAIRCovis Pharma Europe B.V.
- NetherlandsBretaris Genuair 322 microgram inhalatiepoederCovis Pharma Europe B.V.
- PolandBretaris GenuairCovis Pharma Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bretaris Genuair, Eklira Genuair
- Liechtenstein · Bretaris Genuair, Eklira Genuair
- Norway · Bretaris Genuair, Eklira Genuair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb088dbd-6d6b-413e-9436-6a255cf01425 GET /v1/drugs/fb088dbd-6d6b-413e-9436-6a255cf01425?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37399011000001107",
"desc": "Eklira 322micrograms/dose Genuair (Mawdsley-Brooks & Company Ltd)",
"form": "Inhalation powder",
"vpid": "38893611000001108",
"source": "dmd",
"vtm_id": "21021511000001105",
"strength": "375 microgram",
"substance": "Aclidinium bromide",
"ingredient": "Aclidinium bromide",
"supplier_code": "15125811000001100"
}See everything about aclidinium bromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.